Instead, strategies that selectively target the tissue-damaging pro-inflammatory and oxidative actions of neutrophil-derived granular enzymes such as MPO will likely be a more appropriate and effective approach for reducing post-MI myocardial damage. The gene discussed is MPO; the disease is myocardial infarction.